NASDAQ:TTOO • US89853L3024
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for T2 BIOSYSTEMS INC (TTOO).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-07-30 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2024-04-29 | Canaccord Genuity | Maintains | Hold -> Hold |
| 2023-07-13 | Alliance Global Partners | Maintains | Neutral -> Neutral |
| 2023-01-24 | Alliance Global Partners | Maintains | Neutral |
| 2022-10-14 | Canaccord Genuity | Downgrade | Buy -> Hold |
| 2022-07-07 | BTIG | Downgrade | Buy -> Neutral |
| 2022-07-07 | Alliance Global Partners | Downgrade | Buy -> Neutral |
| 2022-02-18 | Alliance Global Partners | Upgrade | Neutral -> Buy |
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 28.06M 54.77% | 22.31M -20.49% | 7.193M -67.76% | 10.812M 50.31% | 23.562M 117.92% | 33.966M 44.16% | 47.124M 38.74% | 62.22M 32.03% | 80.07M 28.69% | 98.124M 22.55% | 112.81M 14.97% | |
| EBITDA YoY % growth | -41.7M -8.17% | -54.15M -29.86% | -46.294M 14.51% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -42.97M -6.73% | -55.2M -28.46% | -47.153M 14.58% | -42.228M 10.44% | -39.576M 6.28% | -38.046M 3.87% | -41.616M -9.38% | -33.762M 18.87% | -21.624M 35.95% | -13.566M 37.26% | -5.304M 60.90% | |
| Operating Margin | -153.14% | -247.42% | -655.54% | -390.57% | -167.97% | -112.01% | -88.31% | -54.26% | -27.01% | -13.83% | -4.70% | |
| EPS YoY % growth | -361.50 -1,471.74% | -1,436.00 -297.23% | N/A 98.68% | -3.16 83.26% | -1.21 61.61% | -0.71 41.18% | -0.57 20.00% | -0.38 33.93% | -0.22 40.54% | N/A | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.60 73.18% | -0.49 81.59% | -0.40 39.73% | -0.33 50.00% | -0.28 54.24% |
| Revenue Q2Q % growth | 3.672M 118.70% | 4.488M 117.76% | 5.304M 171.72% | 6.324M 218.59% | 7.548M 105.56% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -11.832M -26.97% | -11.934M 5.29% | -12.036M -25.70% | -11.934M -17.45% | -11.73M 0.86% |
All data in USD
6 analysts have analysed TTOO and the average price target is 5.1 USD. This implies a price increase of 3705.97% is expected in the next year compared to the current price of 0.134.
T2 BIOSYSTEMS INC (TTOO) will report earnings on 2025-05-05.
The consensus EPS estimate for the next earnings of T2 BIOSYSTEMS INC (TTOO) is -0.6 USD and the consensus revenue estimate is 3.67M USD.
The consensus rating for T2 BIOSYSTEMS INC (TTOO) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.